For information about Africhol's programs and activities, please contact:
Latest News, Outbreak Notifications:
Follow Africhol on Twitter
Global Cholera Therapeutics Pipeline Review 2014 - 5 Drug Profiles From 3 Companies
BusinessWire (11 Sep 2014)
Research and Markets has announced the addition of the "Cholera - Pipeline Review, H2 2014" report to their offering. This report provides comprehensive information on the therapeutic development for Cholera, complete with...
Cholera against cholera: an interview with Dr Bruce Turnbull, University of Leeds
News-Medical.net (8 Sep 2014)
Cholera bacteria, and other types of bacteria that cause diarrheal diseases, infect your intestines where they release AB5 protein toxins – that is they have a single toxic A-subunit that is linked to...
War Between Bacteria and Phages Benefits Humans
Tufts University (2 Sep 2014)
In the battle between our immune systems and cholera bacteria, humans may have an unknown ally in bacteria-killing viruses known as phages.
Major Milestones for Development of Korea’s First Cholera Vaccine for the World’s Poor
ivi.int (27 Aug 2014)
EuBiologics Co., Ltd. (EuBiologics) and the International Vaccine Institute (IVI) announced today that major milestones have been met in their collaborative efforts to develop an oral cholera vaccine (OCV) for use in developing countries.